Kerna Ventures
Kerna Ventures is an early-stage venture capital firm founded in 2022 and based in London, with additional offices in San Francisco and Abu Dhabi. The firm focuses on investing in advanced therapeutic platform technologies, particularly in areas such as genome engineering, cell reprogramming, computational biology, genetic medicine, and targeted drug delivery. Kerna Ventures typically invests from seed through Series A, providing funding between $500,000 and $5 million. The firm supports startups emerging from academic research institutions by offering access to talent, capital for future rou
Investing activity
Kerna Ventures appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $18M. The rounds are mostly Seed, with a median round size of $18M. The most recent is Undecimal Bio (Seed, $18M, Oct 2026).
Kerna Ventures most often invests alongside 4BIO Capital, IQ Capital, Entrée Capital and Verve Ventures, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Kerna Ventures
What AI companies has Kerna Ventures invested in?
Kerna Ventures's AI investments include Undecimal Bio. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Kerna Ventures based?
Kerna Ventures is based in Schaumburg, Illinois, United States.
What stage does Kerna Ventures invest at?
In the rounds tracked on AI Lounge, Kerna Ventures has invested at Seed, with a median round of $18M.
Who does Kerna Ventures co-invest with?
Kerna Ventures's most frequent co-investors on AI Lounge are 4BIO Capital (1 deal), IQ Capital (1 deal), Entrée Capital (1 deal), Verve Ventures (1 deal) and Harel Insurance and Financial (1 deal).
How can founders reach Kerna Ventures?
Founders on AI Lounge can see Kerna Ventures's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Kerna Ventures to their Investor Pipeline to track the conversation.